The TERT/CLPTM1L region is frequently identified by GWAS for conferring tumor risk for many tumor types, including pancreatic, lung, melanoma, and bladder cancers (see refs 16, 17 for meta-analyses). The gene discussed is TERT; the disease is urinary bladder carcinoma.